Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: A systematic analysis of the global burden of disease study 2019

被引:29
作者
Wang, Dan [1 ]
Xu, Yanbing [1 ]
Zhu, Zizhao [2 ]
Li, Yanliang [3 ,4 ]
Li, Xiaowen [1 ]
Li, Yike [1 ]
Shen, Hui [1 ]
Wu, Wei [2 ]
Liu, Yazhuo [1 ]
Han, Cheng [1 ]
机构
[1] Dalian Univ, Affiliated Zhongshan Hosp, Dept Clin Nutr & Metab, Dalian, Peoples R China
[2] Sixth Peoples Hosp Shenyang, Dept Gen Surg, Shenyang, Peoples R China
[3] Univ Illinois, Dept Ophthalmol, Chicago, IL USA
[4] Univ Illinois, Dept Visual Sci, Chicago, IL USA
来源
FRONTIERS IN NUTRITION | 2022年 / 9卷
基金
中国国家自然科学基金;
关键词
non-alcoholic fatty liver disease; GBD study; sociodemographic index; risk factors; economic burden; FATTY LIVER-DISEASE; ASIA-PACIFIC REGION; NONALCOHOLIC STEATOHEPATITIS; UNITED-STATES; EPIDEMIOLOGY; PREVALENCE; MORTALITY; CHALLENGES; MANAGEMENT; AFRICA;
D O I
10.3389/fnut.2022.1047129
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BackgroundUnderstanding the burdens and trends of non-alcoholic fatty liver disease (NAFLD) is necessary for developing effective intervention strategies. In this study, Global Burden of Disease (GBD) 2019 study data were extracted and analyzed to elucidate trends of NAFLD. MethodsThe prevalence, incidence, disability-adjusted life year (DALY), and death rates of NAFLD in geographic populations worldwide from 1990 to 2019 were extracted from the GBD 2019 study data. The global temporal trend of NAFLD from 1990 to 2019 was evaluated using estimated annual percentage changes (EAPCs) and age-standardized rates. ResultsGlobally, between 1999 and 2019, the age-standardized prevalence rate of NAFLD increased, with EAPCs of 0.77 [95% CI (0.69, 0.85)], whereas the DALY and Death rates decreased, with EAPCs of -0.82 [95% CI (-0.92, -0.71)], and -0.67 [95% CI (-0.76, -0.58)], respectively. Geographically, the age-standardized prevalence rate showed the most serious upward trend in high-income North America with an EAPC of 0.98 [95% CI (0.95, 1.02)], and the age-standardized incidence rate showed an upward trend in Central Asia with an EAPC of 3.17 [95% CI (2.2, 2.49)]. The most significant upward trend of DALY and death rates appeared in Eastern Europe, with EAPCs of 4.06 [95% CI (3.31, 4.82)], and 3.36 [95% CI (2.77, 3.96)], respectively. At the country level, the age-standardized rates showed an upward trend in Armenia, Belarus, and Republic of Korea. Regarding age groups, the percentage change of prevalence was the highest in the 40 to 44 group [0.29 (0.26, 0.34)] from 1990 to 2019; the percentage change of incidence was the highest in the 85 to 89 group [0.46 (0.12, 0.71)] from 1990 to 2019; the percentage change of DALY was the highest in the 80 to 84 group [0.25 (0.11, 0.39)] from 1990 to 2019; and the percentage change of death rate was the highest in the 15 to 19 group [0.36 (0.17, 0.60)] from 1990 to 2019. The percentage change of prevalence of liver cancer due to NASH was the highest in the group of 85 to 89, whereas those of incidence, DALY, and death were the highest in the group above 95 from 1990 to 2019. Regarding the sociodemographic index (SDI), the highest age-standardized prevalence, incidence, and Death rates of NAFLD occurred in middle-SDI countries, and the highest DALY rates of NAFLD occurred in low-SDI countries. ConclusionGlobal NAFLD burdens have increased since 1990. Our findings provide a reference for policymakers to reduce the burden of NAFLD, especially in middle and low-SDI countries.
引用
收藏
页数:12
相关论文
共 45 条
[1]  
Abbafati C, 2020, LANCET, V396, P1204
[2]   Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative [J].
Chan, W-K. ;
Treeprasertsuk, S. ;
Imajo, K. ;
Nakajima, A. ;
Seki, Y. ;
Kasama, K. ;
Kakizaki, S. ;
Fan, J-G. ;
Song, M. J. ;
Yoon, S. K. ;
Dan, Y-Y. ;
Lesmana, L. ;
Ho, K-Y. ;
Goh, K-L. ;
Wong, V. W-S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (06) :816-825
[3]   Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH) [J].
Chawla, Kashmira S. ;
Talwalkar, Jayant A. ;
Keach, Jill C. ;
Malinchoc, Michael ;
Lindor, Keith D. ;
Jorgensen, Roberta .
BMJ OPEN GASTROENTEROLOGY, 2016, 3 (01)
[4]  
Eiszrich Adam, 2007, Orv Hetil, V148, P2461, DOI 10.1556/OH.2007.28270
[5]   Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up [J].
Ekstedt, Mattias ;
Hagstrom, Hannes ;
Nasr, Patrik ;
Fredrikson, Mats ;
Stal, Per ;
Kechagias, Stergios ;
Hultcrantz, Rolf .
HEPATOLOGY, 2015, 61 (05) :1547-1554
[6]   New trends on obesity and NAFLD in Asia [J].
Fan, Jian-Gao ;
Kim, Seung-Up ;
Wong, Vincent Wai-Sun .
JOURNAL OF HEPATOLOGY, 2017, 67 (04) :862-873
[7]   Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 [J].
Feigin, Valery L. ;
Stark, Benjamin A. ;
Johnson, Catherine Owens ;
Roth, Gregory A. ;
Bisignano, Catherine ;
Abady, Gdiom Gebreheat ;
Abbasifard, Mitra ;
Abbasi-Kangevari, Mohsen ;
Abd-Allah, Foad ;
Abedi, Vida ;
Abualhasan, Ahmed ;
Abu-Rmeileh, Niveen Me ;
Abushouk, Abdelrahman, I ;
Adebayo, Oladimeji M. ;
Agarwal, Gina ;
Agasthi, Pradyumna ;
Ahinkorah, Bright Opoku ;
Ahmad, Sohail ;
Ahmadi, Sepideh ;
Salih, Yusra Ahmed ;
Aji, Budi ;
Akbarpour, Samaneh ;
Akinyemi, Rufus Olusola ;
Al Hamad, Hanadi ;
Alahdab, Fares ;
Alif, Sheikh Mohammad ;
Alipour, Vahid ;
Aljunid, Syed Mohamed ;
Almustanyir, Sami ;
Al-Raddadi, Rajaa M. ;
Salman, Rustam Al-Shahi ;
Alvis-Guzman, Nelson ;
Ancuceanu, Robert ;
Anderlini, Deanna ;
Anderson, Jason A. ;
Ansar, Adnan ;
Antonazzo, Ippazio Cosimo ;
Arabloo, Jalal ;
Arnlov, Johan ;
Artanti, Kurnia Dwi ;
Aryan, Zahra ;
Asgari, Samaneh ;
Ashraf, Tahira ;
Athar, Mohammad ;
Atreya, Alok ;
Ausloos, Marcel ;
Baig, Atif Amin ;
Baltatu, Ovidiu Constantin ;
Banach, Maciej ;
Barboza, Miguel A. .
LANCET NEUROLOGY, 2021, 20 (10) :795-820
[8]   NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options [J].
Foerster, Friedrich ;
Gairing, Simon Johannes ;
Mueller, Lukas ;
Galle, Peter Robert .
JOURNAL OF HEPATOLOGY, 2022, 76 (02) :446-457
[9]  
Ge Xiaojun, 2020, BMJ Open, V10, pe036663, DOI 10.1136/bmjopen-2019-036663
[10]   Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults [J].
George, Elena S. ;
Forsyth, Adrienne ;
Itsiopoulos, Catherine ;
Nicoll, Amanda J. ;
Ryan, Marno ;
Sood, Siddharth ;
Roberts, Stuart K. ;
Tierney, Audrey C. .
ADVANCES IN NUTRITION, 2018, 9 (01) :30-40